-
FDA Developing Digital Device Certification Process
The U.S. Food and Drug Administration expects to unveil a new procedure for certifying digital medical devices that the agency says should speed their entry to the market.
-
Cancer Drug Produced in Small Continuous-Flow Batches
A team from drug maker Eli Lilly & Company devised techniques for producing an experimental cancer drug in small quantities but with safe, economical methods used in continuous flow manufacturing.
-
Coalition to Make 10,000 Open-Access Synthetic Genes
A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers.
-
$300M Fund to Back European Life Science Companies
A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development.
-
First Agricultural Crispr Products Expected by 2020
While the genome editing technique known as Crispr is generating discussion in the health field, its first commercial applications are likely to be in agriculture.
-
3-D Printed Patch Helps Grow New Blood Vessels
A biomedical engineering team developed a printed patch infused with cells that in lab animals grows new blood vessels to counteract blocked or hardened arteries.
-
Brain-Computer Device Tested with Consciousness Patients
Tests of a device designed for people with consciousness disorders to provide basic feedback to questions show the system can elicit and capture responses from these individuals.
-
Supreme Court Cuts Biosimilar Waiting Time
The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products.
-
Institutions to Apply AI Models to Type 1 Diabetes
A children’s hospital and diabetes research center are evaluating techniques using artificial intelligence to better identify and manage the care of people with type 1 diabetes.
-
Cancer Center to Test Focused Radiation Therapy
MD Anderson Cancer Center is testing new radiation treatments for cancer designed to reduce adverse side effects of conventional radiation therapy.